Cargando…

Treatments of osteoporosis increase bone material strength index in patients with low bone mass

SUMMARY: Effects on bone material properties of two-year antiosteoporotic treatment were assessed using in vivo impact microindentation (IMI) in patients with low bone mineral density (BMD) values. Antiresorptive treatment, in contrast to vitamin D ± calcium treatment alone, induced BMD-independent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoeb, M., Malgo, F., Peeters, J. J. M., Winter, E. M., Papapoulos, S. E., Appelman-Dijkstra, N. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423791/ https://www.ncbi.nlm.nih.gov/pubmed/32270252 http://dx.doi.org/10.1007/s00198-020-05375-3

Ejemplares similares

Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures
por: Schoeb, M., et al.
Publicado: (2022)

Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site
por: Malgo, F., et al.
Publicado: (2017)

Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2015)

Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism
por: Schoeb, Manuela, et al.
Publicado: (2021)

Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature
por: Schoeb, Manuela, et al.
Publicado: (2020)

Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)

From disease to treatment: from rare skeletal disorders to treatments for osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)

Increased Bone Resorption during Lactation in Pycnodysostosis
por: Jansen, Ineke D.C., et al.
Publicado: (2021)

High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD
por: Malgo, F., et al.
Publicado: (2016)

Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
por: Ueland, Thor, et al.
Publicado: (2019)

Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands
por: Schoeb, Manuela, et al.
Publicado: (2023)

Chronobiology and Chronotherapy of Osteoporosis
por: Winter, Elizabeth M, et al.
Publicado: (2021)

Labisia pumila Prevents Complications of Osteoporosis by Increasing Bone Strength in a Rat Model of Postmenopausal Osteoporosis
por: Fathilah, Siti Noor, et al.
Publicado: (2012)

Bone Strength/Bone Mass Discrepancy in Glucocorticoid‐Treated Adult Mice
por: Dubrovsky, Alanna M., et al.
Publicado: (2020)

Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption
por: Doyle, N., et al.
Publicado: (2017)

Associations between Bone Material Strength Index, Calcaneal Quantitative Ultrasound, and Bone Mineral Density in Men
por: Rufus-Membere, Pamela, et al.
Publicado: (2020)

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats
por: Suen, Pui Kit, et al.
Publicado: (2015)

Combination and sequential treatments in the management of osteoporosis
por: Papapoulos, Socrates
Publicado: (2012)

Calcium- and Phosphorus-Supplemented Diet Increases Bone Mass after Short-Term Exercise and Increases Bone Mass and Structural Strength after Long-Term Exercise in Adult Mice
por: Friedman, Michael A., et al.
Publicado: (2016)

NOTUM inhibition increases endocortical bone formation and bone strength
por: Brommage, Robert, et al.
Publicado: (2019)

Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone
por: Rotman, Marlous, et al.
Publicado: (2018)

Low Grip Strength and Muscle Mass Increase the Prevalence of Osteopenia and Osteoporosis in Elderly Women
por: Lee, Kyujin, et al.
Publicado: (2021)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
por: Peng, Jia, et al.
Publicado: (2021)

Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration
por: Miazgowski, Tomasz, et al.
Publicado: (2012)

Osteopenia and Osteoporosis in Patients with Bronchiectasis: Association with Respiratory Parameters, Body Composition, Muscle Strength and Bone Remodeling Biomarkers
por: Contreras-Bolívar, V., et al.
Publicado: (2019)

Mechanical basis of bone strength: influence of bone material, bone structure and muscle action
por: Hart, N.H., et al.
Publicado: (2017)

Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey
por: Peeters, Joséphine Jeanne Maria, et al.
Publicado: (2021)

Does osteoporosis affect the healing of subcapital humerus and distal radius fractures?
por: Gorter, E.A., et al.
Publicado: (2020)

For older individuals there is greater variance in low mean Bone Material Strength Index values obtained with the OsteoProbe
por: Anderson, Kara B., et al.
Publicado: (2023)

Type 2 Diabetes Mellitus Increases the Risk to Hip Fracture in Postmenopausal Osteoporosis by Deteriorating the Trabecular Bone Microarchitecture and Bone Mass
por: Mohsin, Sahar, et al.
Publicado: (2019)

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
por: Hamdy, Ronald C
Publicado: (2010)

Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength
por: Chellaiah, Meenakshi, et al.
Publicado: (2000)

Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis
por: Malgo, F., et al.
Publicado: (2017)

Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia
por: Chandler, H., et al.
Publicado: (2019)

Systemic immune-inflammation index is associated with decreased bone mass density and osteoporosis in postmenopausal women but not in premenopausal women
por: Zhang, Jiaxin, et al.
Publicado: (2023)

FRI681 Osteoboost(Tm) Is Effective In Preserving Bone Strength And Density Of The Spine In Women With Low Bone Mass
por: Bilek, Laura D, et al.
Publicado: (2023)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle, Ovidiu Alexandru, et al.
Publicado: (2018)

Higher Hand Grip Strength Is Associated With Greater Radius Bone Size and Strength in Older Men and Women: The Framingham Osteoporosis Study
por: McLean, Robert R., et al.
Publicado: (2021)

Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions
por: Lane, N.E., et al.
Publicado: (2019)

Prevalence of Osteoporosis and Low Bone Mass in Older Chinese Population Based on Bone Mineral Density at Multiple Skeletal Sites
por: Lu, Yi-Chien, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6vobp00m28mp1nig8rvil67u9f